Main Menu

Welcome to BOPA

Latest news from BOPA

For details on the forthcoming

BOPA Study Days

BOPA are hosting 4 study days with Dr Elaine Vickers on the following topics:

  • The Science of Targeted Cancer Treatments: 19th & 22nd May 2015

  • Targeted Treatments for Haematological: 8th & 9th September 2015

Click here for more information

First Early Access to Medicines (EAMS) Scientific Opinion issued by MHRA

The MHRA has issued its first Early Access to Medicines (EAMS) scientific opinion.

It is for a product called pembrolizumab, used to treat advanced melanoma which has spread or cannot be removed by surgery and has progressed after other treatments.  The MHRA assessment team considered that pembrolizumab had been shown to slow the progression of cancer in a condition where other treatments currently have poor results.

Details of the scientific opinion ( can be found on the MHRA website, as well as background information on EAMS (

For more information on the

BOPA 18th Annual Symposium please click here

For older news items please click here

To pay your conference fees

2013 BOPA Conference fees
2014 BOPA Conference fees